DAMAE Medical Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 32

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 14

DAMAE Medical General Information

Description

Developer of an in-vivo imaging technology designed to revolutionize skin cancer diagnosis. The company's platform is based on proprietary technology that offers cellular-resolution imaging of the skin similar to histology without the need for tissue excision and processing, enabling immediate and non-invasive diagnosis of skin cancers and helping dermatologists to have a deep look at the skin.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Corporate Office
  • 14 rue Sthrau
  • 75013 Paris
  • France
+33 01 00 00 00 00

DAMAE Medical Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DAMAE Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Secondary Transaction - Private 00.000 Completed Generating Revenue
10. Later Stage VC (Series A) 03-Feb-2022 00.000 00.000 000.00 Completed Generating Revenue
9. Secondary Transaction - Private 10-Sep-2020 00.000 Completed Generating Revenue
8. Grant 01-Sep-2019 00.000 00.000 Completed Generating Revenue
7. Seed Round 19-Apr-2017 00.000 00.000 00.000 Completed Generating Revenue
6. Accelerator/Incubator 13-Oct-2015 00000 Completed Startup
5. Grant 05-Jul-2015 000.00 00000 Completed Startup
4. Accelerator/Incubator 05-Jun-2015 00000 Completed Startup
3. Accelerator/Incubator 24-Mar-2015 $109K $109K Completed Startup
2. Accelerator/Incubator 01-Jan-2015 Completed Startup
To view DAMAE Medical’s complete valuation and funding history, request access »

DAMAE Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
P Shares 100,000 $0.113144 $22.63 $22.63 1x $22.63 22.25%
To view DAMAE Medical’s complete cap table history, request access »

DAMAE Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an in-vivo imaging technology designed to revolutionize skin cancer diagnosis. The company's platform is ba
Diagnostic Equipment
Paris, France
32 As of 2023
00.000
000000 - 000 00.000

000000

erit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur s
0000000000 000000000
Maidstone, United Kingdom
00 As of 0000
000.00
00.000 0000-00-00
0000000000 0 000.00

000000

citation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
0000000000 000000000
Stockholm, Sweden
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DAMAE Medical Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
VivoSight Venture Capital-Backed Maidstone, United Kingdom 00 000.00 0000000000 0 000.00
SciBase Formerly PE-Backed Stockholm, Sweden 00 000.00 000000000 000.00
Skin Analytics Venture Capital-Backed Cambridge, United Kingdom 00 000.00 00000000000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

DAMAE Medical Patents

DAMAE Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3128627-A1 Systems and methods for characterizing a region of interest of a biological tissue Pending 29-Oct-2021 000000000 0
AU-2022377223-A1 Systems for characterizing a region of interest of a biological tissue Pending 29-Oct-2021
FR-3119466-B1 Devices for ex vivo microscopic analysis of samples and in vivo of skin Active 29-Jan-2021 000000000
FR-3119466-A1 Devices for ex vivo microscopic analysis of samples and in vivo of skin Active 29-Jan-2021 000000000 0
EP-4285174-A1 Devices for ex vivo microscopic analysis of samples and in vivo microscopic analysis of the skin Pending 29-Jan-2021 G02B21/33
To view DAMAE Medical’s complete patent history, request access »

DAMAE Medical Executive Team (3)

Name Title Board Seat Contact Info
Anaïs Barut Co-Founder, Président & Chief Executive Officer
David Siret Co-Founder, Directeur général & Chief Technology Officer
Arnaud Dubois Co-Founder & Chief Scientific Officer
To view DAMAE Medical’s complete executive team members history, request access »

DAMAE Medical Board Members (2)

Name Representing Role Since
Isabel Marey-Semper Ph.D Self Board Member 000 0000
Philippe Peltier Kurma Partners Board Member 000 0000
To view DAMAE Medical’s complete board members history, request access »

DAMAE Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DAMAE Medical Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BNP Paribas Développement PE/Buyout Minority 000 0000 000000 0
Kurma Partners Venture Capital Minority 000 0000 000000 0
News Invest Corporation Minority 000 0000 000000 0
Partech Venture Capital Minority 000 0000 000000 0
Phoenix Labs PE-Backed Company Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

DAMAE Medical FAQs

  • When was DAMAE Medical founded?

    DAMAE Medical was founded in 2014.

  • Who is the founder of DAMAE Medical?

    Anaïs Barut, David Siret, and Arnaud Dubois are the founders of DAMAE Medical.

  • Who is the CEO of DAMAE Medical?

    Anaïs Barut is the CEO of DAMAE Medical.

  • Where is DAMAE Medical headquartered?

    DAMAE Medical is headquartered in Paris, France.

  • What is the size of DAMAE Medical?

    DAMAE Medical has 32 total employees.

  • What industry is DAMAE Medical in?

    DAMAE Medical’s primary industry is Diagnostic Equipment.

  • Is DAMAE Medical a private or public company?

    DAMAE Medical is a Private company.

  • What is DAMAE Medical’s current revenue?

    The current revenue for DAMAE Medical is 000000.

  • How much funding has DAMAE Medical raised over time?

    DAMAE Medical has raised $8.07M.

  • Who are DAMAE Medical’s investors?

    BNP Paribas Développement, Kurma Partners, News Invest, Partech, and Phoenix Labs are 5 of 14 investors who have invested in DAMAE Medical.

  • Who are DAMAE Medical’s competitors?

    VivoSight, SciBase, and Skin Analytics are competitors of DAMAE Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »